pindolol has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gustafson, I | 1 |
| Westerberg, EJ | 1 |
| Wieloch, T | 1 |
| Nishino, K | 1 |
| Davis, JN | 1 |
2 other studies available for pindolol and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Effects of ischemia on regional ligand binding to adrenoceptors in the rat brain.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Brain; Dioxanes; Idazoxan; Ischemic Attack, T | 1992 |
Rapid reduction in [3H]prazosin binding to gerbil forebrain membranes during bilateral common carotid artery occlusion.
Topics: Animals; Carotid Arteries; Cell Membrane; Cell Survival; Diencephalon; Gerbillinae; Ischemic Attack, | 1989 |